We must not use it if we are pregnant, breastfeeding, or underage
And the government needs to intervene, requiring Medicare to treat obesity as a chronic condition and initiating coverage for Part D enrollees who are prescribed a GIP or GLP-1 medication solely for the treatment of weight loss, rather than restricting coverage to those with diabetes or cardiovascular disease
Meet Enzene at DCAT Week Venue: Suite 1636, The Lexington Hotel, New York City Lets discuss how we can support your next biologics program
The mechanisms that drive this association include systemic inflammation, endothelial dysfunction, oxidative stress, hypertension, and metabolic dysfunction
To understand the effect of a drug, it has to be measured against something else